TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
INDP

Indaptus Therapeutics Inc

Healthcare · Biotechnology

2.10$ -7.8% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement INDP
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – – –
– +27.5% -6.0% +18.3% +3.6% -0.6% -99.9% +64.7% +26.9% -27.9% -42.8% –
– – – – – – – – – – – –
– -7.0% +146.5% +141.2% +45.7% -24.7% -90.0% -5.0% +150.7% +20.5% -4.9% +28.8%
– – – – – – +74.0% +451.3% +64.9% +2.0% -7.3% +29.3%
– -1.8% +91.8% +117.6% +48.4% -19.7% -89.4% +114.7% +92.9% +9.8% -6.2% +29.1%
– – – – – – – – – – – –
– – – +6.3% +35.3% -34.8% +0.8% +17.3% +3,218.5% – – –
– – – – – – – – – – – –
– – – – +255.2% +519.4% -102.4% – – – – –
– – – – – – – – – – – –
– – – – – – – – – – – –

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?